Physician profile
Vijaykumar B Patel
NPI 1043223431
$1,709.02
in general payments reported to CMS, 2019-2025
17 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $874 · 2020: $47.62 · 2021: $211 · 2022: $236 · 2023: $102 · 2024: $113 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $333.58 | 2019 | |
| Nestle Healthcare Nutrition INC. | $214.55 | 2021-2022 | |
| Allergan, INC. | $200.99 | 2019 | |
| Horizon Therapeutics Plc | $124.95 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.93 | 2019 | |
| Melinta Therapeutics, LLC | $112.50 | 2024 | Kimyrsa |
| Pfizer INC. | $102.60 | 2019-2025 | |
| Inspire Medical Systems, INC. | $95.93 | 2025 | Inspire |
| Merck Sharp & Dohme LLC | $90.29 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $89.17 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $59.09 | 2019-2021 | |
| Angiodynamics, INC. | $51.37 | 2021 | |
| Novo Nordisk INC | $36.87 | 2019-2021 | |
| Lilly USA, LLC | $23.33 | 2019 | |
| Amgen INC. | $22.91 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $13.00 | 2023 | Shingrix |
| Sanofi-Aventis U.S. LLC | $12.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vijaykumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.